Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
H3 histone pseudogene 18 (H3P18) is a **pseudogene**—a gene sequence that resembles the gene for a canonical or variant H3 family histone, specifically the H3.3B variant, but lacks the necessary elements to produce a functional protein. In contrast to coding members of the H3 family—which play critical roles in nucleosome structure, chromatin dynamics, and epigenetic regulation—H3P18 does not encode a protein and therefore does not have a known physiological function or implications as a drug target[1][2]. The designation as a pseudogene implies it arose from gene duplication or retrotransposition events, but acquired mutations that inactivate protein production. There is no evidence in the scientific literature that H3P18 has a role in human disease, nor is it a pharmacological target or biomarker. **Context and Supporting Details:** - **Histone H3** is a central nucleosome component and subject to extensive post-translational modification, and active variants including H3.3 are involved in transcription regulation and chromatin dynamics[1][2]. - A pseudogene such as H3P18 is a nonfunctional remnant, sharing sequence similarity but not producing protein; such entities are not considered canonical molecular targets for drug development, diagnostics, or research into biochemical pathways. - No drugs, biomarkers, disease associations, or distinct molecular functions are reported for H3P18[1][2]. - H3mm18, a mouse-specific H3.3-like variant, is sometimes discussed in the context of variant function, but is distinct from pseudogenes and not directly related to the human H3P18 pseudogene[1]. **Summary:** **H3 histone pseudogene 18** is not a functional molecular target. It is a non-coding pseudogene, not associated with a physiological or pathological role, and should not be considered as a valid or actionable therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H3 histone pseudogene 18 (H3P18).